Business Wire
BusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex Times
Back to front
IRS scrutinizes UnitedHealth tax planning through foreign subsidiaries, seeking to raise taxable income for multiple years
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 19, 5:25 AM EDT

IRS scrutinizes UnitedHealth tax planning through foreign subsidiaries, seeking to raise taxable income for multiple years

The agency is challenging how UnitedHealth moved money across borders, arguing the company’s U.S. taxable income should be higher for four consecutive tax years. UnitedHealth did not say what the dispute involves in dollars, and both sides declined to estimate potential impact.

The Internal Revenue Service is examining UnitedHealth’s use of foreign subsidiaries and is seeking to increase the company’s taxable income for four straight years, according to a report published Tuesday.

The dispute centers on how UnitedHealth transferred money through overseas entities. The IRS position, as described in the report, is that the company should have had more taxable income in the United States during the years under review, implying the tax benefit from certain cross-border arrangements was too low.

The report says the IRS wants to raise the health insurer’s taxable income over a multi-year period, but it does not provide the amount the government is seeking or any specific breakdown of the adjustments it believes are needed.

UnitedHealth, in turn, did not disclose details in the coverage on the size of its exposure, the specific tax positions at issue, or whether it plans to settle or contest the claims in court.

While the reporting does not identify the disputed structures beyond the broad use of foreign subsidiaries, the IRS’s approach reflects a common theme in large-cap audits: regulators scrutinize whether intercompany payments and related pricing and allocation methods shift profits away from U.S. tax bases.

The IRS investigation comes at a time when U.S. health insurers and other large multinationals face persistent attention from tax authorities on cross-border operations. These reviews often involve transfer pricing concepts, where the tax outcome depends on how transactions between related entities are priced and allocated across jurisdictions.

For investors and industry observers, the key uncertainty is the financial magnitude. Without disclosed dollar figures, it is not possible from the reporting alone to gauge whether any eventual assessment would be material relative to UnitedHealth’s earnings or cash flow, or whether the company could benefit from tax dispute provisions already reflected in its financial statements.

The next steps will likely depend on the audit and dispute-resolution process, including whether the IRS and UnitedHealth reach an agreement or escalate the matter to formal proceedings. Until more information is filed through regulatory channels or made public in the context of the dispute, the practical question is how quickly the matter moves from examination to resolution and what it ultimately costs, if anything.

Why It Matters

  • Cross-border tax disputes can create unexpected liabilities for multinationals, even when headline financial results remain unaffected in the near term.
  • If the IRS successfully recharacterizes intercompany arrangements, it can increase future tax costs and complicate earnings forecasting.
  • The case underscores ongoing enforcement focus on how large companies allocate income across U.S. and foreign entities.
  • Any eventual settlement or court outcome could influence how similar structures are priced and documented across the sector.

Sources

Key Facts

  • The IRS is scrutinizing UnitedHealth’s movement of money through foreign subsidiaries.
  • The IRS is seeking to increase UnitedHealth’s taxable income for four consecutive tax years.
  • The coverage does not provide specific dollar figures for the requested tax adjustments or penalties.
  • UnitedHealth did not disclose how much is at stake or the specifics of the disputed tax treatment in the reported account.
  • Both sides declined to quantify the impact in the published report.

Healthcare Related

IRS scrutinizes UnitedHealth tax planning through foreign subsidiaries, seeking to raise taxable income for multiple years | The Apex Times